KCT0005510招募中未知
A 8 weeks, multi-center, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of enzyme-treated Zizania latifolia (Griseb.) Turcz. ex Stapf extract powder on improvement of Liver function
Wonkwang University Oriental Medical Hospital, Jeonju0 个研究点目标入组 100 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •1)Males and females aged over 19 years at the screening examination
- •2)Participants with 46 U/L=Alanine Transaminase(ALT), 65 U/L=Gamma-glutamyl transferase(GGT)
- •3)Participants who consume alcohol more than 14 unit/weeks for men and 7 unit/weeks for women
- •4)Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions
排除标准
- •1) GGT, ALT or AST > 3-fold of normal range
- •2) Individual with cirrosis, liver cancer or sign of liver cancer
- •3) Taking the liver function improving supplements or medicine within previous 1 month
- •4) Participation in other clinical trials within the previous 3 months
- •5) Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
研究者
相似试验
招募中
Unknown
A human trial of Agrimonia pilosa extract powder on improvement of Liver functioKCT0008689Wonkwang University, Gwangju Medical Center100
招募中
不适用
A 8 week, multi-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of Magnolia extract on gingival healthKCT0006746O100
已完成
不适用
A 8 week, multi-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of MAEC on gingival healthCongenital malformations, deformations and chromosomal abnormalitiesKCT0005569MedibioLAB100
进行中（未招募）
不适用
An 8-week, multicenter, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of the combination of valsartan/HCTZ/amlodipine compared to valsartan/HCTZ, valsartan/amlodipine, and HCTZ/amlodipine in patients with moderate to severe hypertensioHypertensionEUCTR2006-000774-70-GBovartis Pharma Services AG2,252
进行中（未招募）
不适用
An 8-week, multicenter, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of the combination of valsartan/HCTZ/amlodipine compared to valsartan/HCTZ, valsartan/amlodipine, and HCTZ/amlodipine in patients with moderate to severe hypertensioHypertensionEUCTR2006-000774-70-SEovartis Pharma Services AG2,252